A prognostic six‐gene expression risk‐score derived from proteomic profiling of the metastatic colorectal cancer secretome

The necessity to accurately predict recurrence and clinical outcome in early stage colorectal cancer (CRC) is critical to identify those patients who may benefit from adjuvant chemotherapy. Here, we developed and validated a gene‐based risk‐score algorithm for patient stratification and personalised...

Descripción completa

Detalles Bibliográficos
Autores principales: Robles, Javier, Pintado‐Berninches, Laura, Boukich, Issam, Escudero, Beatriz, de los Rios, Vivian, Bartolomé, Rubén A, Jaén, Marta, Martín‐Regalado, Ángela, Fernandez‐Aceñero, María Jesús, Imbaud, Juan Ignacio, Casal, José Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535096/
https://www.ncbi.nlm.nih.gov/pubmed/36134447
http://dx.doi.org/10.1002/cjp2.294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535096/
https://www.ncbi.nlm.nih.gov/pubmed/36134447
http://dx.doi.org/10.1002/cjp2.294

Ejemplares similares